Anthony Atala to Kidney Neoplasms
This is a "connection" page, showing publications Anthony Atala has written about Kidney Neoplasms.
Connection Strength
6.710
-
Atala A. Re: Estrogen Receptor ß Promotes Renal Cell Carcinoma Progression via Regulating LncRNA HOTAIR-miR-138/200c/204/217 Associated CeRNA Network. J Urol. 2019 09; 202(3):461.
Score: 0.567
-
Atala A. Re: A CCR4 Antagonist Reverses the Tumor-Promoting Microenvironment of Renal Cancer. J Urol. 2018 04; 199(4):896.
Score: 0.508
-
Atala A. Re: Analysis of Renal Cancer Cell Lines from Two Major Resources Enables Genomics-Guided Cell Line Selection. J Urol. 2018 02; 199(2):346.
Score: 0.503
-
Atala A. Re: MYC Activation Cooperates with Vhl and Ink4a/Arf Loss to Induce Clear Cell Renal Cell Carcinoma. J Urol. 2018 01; 199(1):31.
Score: 0.499
-
Atala A. Re: Inactivation of the PBRM1 Tumor Suppressor Gene Amplifies the HIF-Response in VHL-/- Clear Cell Renal Carcinoma. J Urol. 2017 10; 198(4):746-748.
Score: 0.491
-
Atala A. Re: The Genomic Landscape of Renal Oncocytoma Identifies a Metabolic Barrier to Tumorigenesis. J Urol. 2017 08; 198(2):258-259.
Score: 0.485
-
Atala A. Re: mTORC1 Drives HIF-1a and VEGF-A Signalling via Multiple Mechanisms Involving 4E-BP1, S6K1 and STAT3. J Urol. 2016 Feb; 195(2):524.
Score: 0.437
-
Atala A. Re: Circulating Biomarkers of One-Carbon Metabolism in Relation to Renal Cell Carcinoma Incidence and Survival. J Urol. 2015 Aug; 194(2):593-4.
Score: 0.423
-
Atala A. Re: Fructose-1,6-bisphosphatase opposes renal carcinoma progression. J Urol. 2015 May; 193(5):1725-6.
Score: 0.415
-
Atala A. Re: Lin28 sustains early renal progenitors and induces Wilms tumor. J Urol. 2015 Feb; 193(2):730-1.
Score: 0.408
-
Atala A. Re: antitumoral effects of vasoactive intestinal peptide in human renal cell carcinoma xenografts in athymic nude mice. J Urol. 2014 Mar; 191(3):866-8.
Score: 0.382
-
Atala A. Re: activation of HIF2a in kidney proximal tubule cells causes abnormal glycogen deposition but not tumorigenesis. J Urol. 2014 Feb; 191(2):555.
Score: 0.380
-
Atala A. Re: Cox-2 inhibition enhances the activity of sunitinib in human renal cell carcinoma xenografts. J Urol. 2013 Sep; 190(3):1132.
Score: 0.370
-
Atala A. Re: therapeutic potential of human mesenchymal stem cells producing IL-12 in a mouse xenograft model of renal cell carcinoma. J Urol. 2011 Feb; 185(2):752.
Score: 0.314
-
Glybochko PV, Alyaev YG, Khokhlachev SB, Fiev DN, Shpot EV, Petrovsky NV, Zhang D, Proskura AV, Yurova M, Matz EL, Wang X, Atala A, Zhang Y, Butnaru DV. 3D reconstruction of CT scans aid in preoperative planning for sarcomatoid renal cancer: A case report and mini-review. J Xray Sci Technol. 2019; 27(2):389-395.
Score: 0.136
-
Atala A. Re: Infiltrating Macrophages Increase RCC Epithelial Mesenchymal Transition (EMT) and Stem Cell-Like Populations via AKT and mTOR Signaling. J Urol. 2017 01; 197(1):51-52.
Score: 0.117
-
Atala A. Re: A Tumor Mitochondria Vaccine Protects against Experimental Renal Cell Carcinoma. J Urol. 2016 07; 196(1):279-81.
Score: 0.112
-
Atala A. Re: Infiltrating Neutrophils Promote Renal Cell Carcinoma (RCC) Proliferation via Modulating Androgen Receptor (AR)???c-Myc Signals. J Urol. 2016 06; 195(6):1947-9.
Score: 0.112
-
Atala A. What's new in urology. J Am Coll Surg. 2004 Sep; 199(3):446-61.
Score: 0.050